Researchers Test Clinical-Grade Watch for Atrial Fibrillation
The prescription wristwatch continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation.
The prescription wristwatch continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation.
Cardiawave SA, a deeptech medical device manufacturer that developed Valvosoft, a non-invasive medical device to treat aortic stenosis, announced the issuance of three new patents in the United States.
Ultromics' EchoGo Heart Failure, an AI solution for echocardiography to help diagnosis heart failure, received FDA clearance.
The prescription wristwatch continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation.
CardieX Limited filed a 510(k) premarket submission with the U.S. FDA for a dual blood pressure and arterial health monitor.
Read MoreResearchers are trying to improve survival odds for those with vascular diseases via an implantable soft electronic monitoring system.
Read MoreThe U.S. FDA provided clearance for Artio Medical’s Solus Gold Embolization Device, a peripheral vascular occlusion product.
Read MoreCardiAMP Cell Therapy technology uses a patient’s bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.
Read MoreRSIP Vision’s new coronary artery modeling tech enables quick and accurate reconstruction of the coronary vasculature during angiography into a 3D model.
Read MoreLungpacer, a company that pioneered a diaphragm pacing therapy system for patients who require mechanical ventilation, won a 2021 innovation competition.
Read MoreNorthern Ireland-based B-Secur has launched an ECG hardware and software development kit to help technology companies fast-track the development of their ECG devices.